protherics Resources | BNET
On TV.com: THE GIRLS NEXT DOOR photos

Resources

14 Resources for

protherics

  • Subscribe to this listing via:
  • RSS
  • Email
Protherics Plc - Holding(s) in Company
Protherics PLC Notification of Major Interests in Shares London, UK; Brentwood, TN, US: 21 March 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces...
Tags: financial, HBOS Plc.
Research articles 2007-03-21
Protherics PLC announces Additional Listing
PROTHERICS ANNOUNCES NASDAQ ADR LISTING AND APPOINTMENT OF PIPER JAFFRAY AS US FINANCIAL ADVISER AND UK JOINT...
Tags: Company, FINANCE, investor, Nasdaq Stock Market Inc., SALES, SEC, SECURITY
Research articles 2005-09-23
Protherics PLC - Major interest in Shares
Protherics PLC Notification of Major Interests in Shares London, UK; Brentwood, TN, US: 16 March 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that...
Tags: FINANCE, financial, Investment, Prudential Insurance Company of America
Research articles 2007-03-16
Protherics PLC announces Major Interest in Shares
Protherics PLC Notification of Major Interests in Shares London, UK; Brentwood, TN, US: 23 November 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company...
Tags: financial, HBOS Plc.
Research articles 2007-11-23
Protherics Plc Announces Final Results
PROTHERICS ANNOUNCES PRELIMINARY RESULTS FOR YEAR ENDED 31 MARCH 2008 Strong increase in underlying revenues and robust financial position Solid progress across...
Tags: AstraZeneca Plc., Company, finance, financial, patient, revenue, tax
Research articles 2008-06-03
PROTHERICS PLC ANNOUNCES - COMMENCE TRADING ON NASDAQ
PROTHERICS ADRS COMMENCE TRADING ON NASDAQ COMPANY TO PRESENT AT THE UBS GLOBAL LIFE SCIENCES CONFERENCE, NEW YORK
Tags: Nasdaq Stock Market Inc.
Research articles 2005-09-27
Protherics PLC announces Appointment of KPMG
Protherics PLC Appointment of Auditors
Tags: KPMG Consulting Inc.
Research articles 2006-12-07
Protherics PLC announces Holding(s) in Company - 1
PROTHERICS PLC NOTIFICATION OF MAJOR INTERESTS IN SHARES 25 January 2006: Protherics PLC, the biopharmaceutical company focused on critical care and oncology (the "Company"), received notification on...
Tags: AstraZeneca Plc., Company
Research articles 2006-01-25
Protherics comes good with GBP195m Astrazeneca deal.
Last December, when Protherics' chief executive Andrew Heath announced that he had eight out of 20 of the world's biggest pharmaceutical companies interested in licensing its sepsis product, Cytofab, the shares reacted positively. But when nothing ha Last December, when Protherics' chief executive Andrew Heath ...
Tags: AstraZeneca Plc.
Research articles 2005-12-16
PROTHERICS (PTI).
Protherics' share price had been hit by a lack of news on its efforts to secure a marketing deal for its antisepsis drug, CytoFab. So the shares leapt on the announcement accompanying these half-year figures that a deal had been done with AstraZeneca Protherics' share price...
Tags: AstraZeneca Plc.
Research articles 2005-12-16
Protherics takes Digitalis to heart.
Protherics has snapped up the marketing rights for heart drug Digitalis Antidot from Roche. The company plans to replace Roche's product with its own drug, Digifab, early next year. Roche's drug is sold in Germany, France and Switzerland, and both pr Protherics has snapped up the...
Tags: Roche Holding AG
Research articles 2006-12-01
Protherics PLC and AstraZeneca Updates CytoFab(TM) Development Programme
Protherics PLC AstraZeneca Updates CytoFabTM Development Programme
Tags: AstraZeneca Plc.
Research articles 2006-11-03
Protherics and AstraZeneca Announce Late Stage Licensing Agreement On CytoFab(TM) For Treatment Of Sepsis
Protherics and AstraZeneca Announce Late Stage Licensing Agreement On CytoFabTM For Treatment Of Sepsis
Tags: agreement, AstraZeneca Plc., licensing agreement
Research articles 2005-12-08
Europe becomes a viable location for biotech innovations; Protherics, Biogen Idec among biotech firms operating successfully in Europe.(GLOBAL EXPANSION: EUROPEAN BIOTECH)
WHILE THE UNITED STATES HAS HISTORICALLY been a dominant player in the field of biotech research, innovation and commercialization, other global communities are striving toward new levels of achievement. Europe is no exception. WHILE THE UNITED STATES HAS HISTORICALLY been a dominant player...
Tags: Biogen Idec Inc., biotechnology, innovation
Research articles 2005-05-01
  • << Previous
  • page 1 of 1
  • Next >>